CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014, Neuro-Oncol, vol.19, issue.S5, pp.1-88, 2017. ,
Glioma in 2014: unravelling tumour heterogeneity-implications for therapy, Nat Rev Clin Oncol, vol.12, pp.69-70, 2015. ,
Integration and analysis of genome-scale data from gliomas, Nat Rev Neurol, vol.7, pp.439-50, 2011. ,
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma, Cancer Cell, vol.22, pp.425-462, 2012. ,
The somatic genomic landscape of glioblastoma, Cell, vol.155, pp.462-77, 2013. ,
The 2016 world health organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, vol.131, pp.803-823, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01479018
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, Science, vol.344, pp.1396-401, 2014. ,
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics, Proc Natl Acad Sci U S A, vol.110, pp.4009-4023, 2013. ,
Neural stem cells and the origin of gliomas, N Engl J Med, vol.353, pp.811-833, 2005. ,
Progenitor cells and glioma formation, Curr Opin Neurol, vol.14, pp.683-691, 2001. ,
, Cancer Treatment Reviews, vol.68, pp.145-154, 2018.
How widespread is adult neurogenesis in mammals?, Nature Rev Neurosci, vol.8, pp.481-489, 2007. ,
Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain, Nature Med, vol.9, pp.439-486, 2003. ,
The interface between glial progenitors and gliomas, Acta Neuropathol, vol.116, pp.465-77, 2008. ,
A perivascular niche for brain tumor stem cells, Cancer Cell, vol.11, pp.69-82, 2007. ,
Neoplasms, differentiations and mutations, Am J Pathol, vol.77, pp.103-121, 1974. ,
PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling, Neuron, vol.51, pp.187-99, 2006. ,
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration, Nature, vol.427, pp.740-744, 2004. ,
Radial glia give rise to adult neural stem cells in the subventricular zone, Proc Natl Acad Sci U S A, vol.101, pp.17528-17560, 2004. ,
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches, Nat Rev Neurosci, vol.12, pp.495-508, 2011. ,
A hierarchy of self-renewing tumorinitiating cell types in glioblastoma, Cancer Cell, vol.17, pp.362-75, 2010. ,
CD133 is a marker of bioenergetic stress in human glioma, PLoS One, vol.3, p.3655, 2008. ,
The stem-cell niche as an entity of action, Nature, vol.441, pp.1075-1084, 2006. ,
Identification of human brain tumour initiating cells, Nature, vol.432, pp.396-401, 2004. ,
Cancer stem cell-vascular endothelial cell interactions in glioblastoma, Biochem Biophys Res Commun, vol.473, pp.688-92, 2016. ,
Emerging therapies for glioblastoma, JAMA Neurol, vol.71, pp.1437-1481, 2014. ,
Mechanisms regulating glioma invasion, Cancer Lett, vol.362, pp.1-7, 2015. ,
WNT signaling in glioblastoma and therapeutic opportunities, Lab Invest, vol.96, pp.137-50, 2016. ,
, Nat Rev Dis Primers, vol.1, p.15017, 2015.
European Association for Neuro-Oncology (EANO) Task Force on Gliomas. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas, Lancet Oncol, vol.18, pp.315-344, 2017. ,
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, pp.459-66, 2009. ,
Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis, J Clin Oncol, vol.23, pp.2411-2433, 2005. ,
Glioma cells release excitotoxic concentrations of glutamate, Cancer Res, vol.59, pp.4383-91, 1999. ,
Autocrine glutamate signaling promotes glioma cell invasion, Cancer Res, vol.67, pp.9463-71, 2007. ,
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma, Sci Transl Med, vol.7, pp.289-86, 2015. ,
Glutamate release promotes growth of malignant gliomas, Nat Med, vol.7, pp.1010-1015, 2001. ,
Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange, J Neurosci, vol.19, pp.10767-77, 1999. ,
Inhibition of cystine uptake disrupts the growth of primary brain tumors, J Neurosci, vol.25, pp.7101-7111, 2005. ,
Glutamate transporters in the biology of malignant gliomas, Cell Mol Life Sci, vol.71, pp.1839-54, 2014. ,
The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo, Cancer Res, vol.65, pp.1934-1974, 2005. ,
Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells, Nat Med, vol.8, pp.971-979, 2002. ,
Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment, PLoS One, vol.4, p.5953, 2009. ,
AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix, Neuro Oncol, vol.11, pp.260-73, 2009. ,
Role of glutamate transporters in redox homeostasis of the brain, Neurochem Int, vol.73, pp.181-91, 2014. ,
Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production, PLoS One, vol.6, p.24665, 2011. ,
Role of ion channels and transporters in cell migration, Physiol Rev, vol.92, pp.1865-913, 2012. ,
Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration, Am J Physiol Cell Physiol, vol.301, pp.541-550, 2011. ,
A neurocentric perspective on glioma invasion, Nat Rev Neurosci, vol.15, pp.455-65, 2014. ,
The roles of K(+) channels in cancer, Nat Rev Cancer, vol.14, pp.39-48, 2014. ,
Membrane channels and transporters in cancers, BBA, vol.1848, pp.2473-2479, 2015. ,
Involvement of potassium channels in the progression of cancer to a more malignant phenotype, BBA, vol.1848, pp.2477-92, 2015. ,
Cortactin controls surface expression of the voltage-gated potassium channel K(V)10.1, J Biol Chem, vol.287, pp.44151-63, 2012. ,
Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas, Neurosci Lett, vol.346, pp.33-39, 2003. ,
Voltage-dependent K+ channels as oncotargets in malignant gliomas, Oncotarget, vol.3, pp.516-523, 2012. ,
Differential expression of a novel voltage gated potassium channel-Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma, Br J Neurosurg, vol.26, pp.16-20, 2012. ,
MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1), Eur J Cancer, vol.49, pp.710-734, 2013. ,
Eag1: an emerging oncological target, Cancer Res, vol.68, pp.1611-1614, 2008. ,
Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival, BMC Cancer, vol.15, p.839, 2015. ,
hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines, Br J Cancer, vol.93, pp.781-92, 2005. ,
BK channels in human glioma cells have enhanced calcium sensitivity, Glia, vol.38, pp.281-91, 2002. ,
Expression and function of calcium-activated potassium channels in human glioma cells, Glia, vol.54, pp.223-256, 2006. ,
The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells, PLoS One, vol.7, p.47825, 2012. ,
Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel, PLoS One, vol.6, p.20362, 2011. ,
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors, J Biol Chem, vol.283, pp.36234-36274, 2008. ,
Effect of extracellular matrix on adhesion, viability, actin cytoskeleton and K+ currents of cells expressing human ether à go-go channels, Life Sci, vol.81, pp.255-65, 2007. ,
herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?, Cancer Res, vol.58, pp.815-837, 1998. ,
Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells, J Biol Chem, vol.278, pp.2947-55, 2003. ,
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression, Sci Signal, vol.10, 2017. ,
HERG K+ channel-dependent apoptosis and cell cycle arrest in human glioblastoma cells, PLoS One, vol.9, p.88164, 2014. ,
Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention, Curr Med Chem, vol.19, pp.661-74, 2012. ,
A Proinvasive Role for the Ca2+-Activated K+ Channel KCa3.1 in Malignant Glioma, Glia, vol.62, pp.971-81, 2014. ,
1 channels are involved in the infiltrative behavior of glioblastoma in vivo, Cell Death Disease, vol.4, p.773, 2013. ,
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma, Cancer Res, vol.61, pp.2744-50, 2001. ,
Ionizing radiation induces migration of glioblastoma cells by activating BK K channels, Radiother Oncol, vol.101, pp.122-128, 2011. ,
Modulation of glioma cell migration and invasion using Cl(-) and K(+) ion channel blockers, J Neurosci, vol.19, pp.5942-54, 1999. ,
Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells, J Neurosci, vol.21, pp.7674-83, 2001. ,
Chloride accumulation drives volume dynamics underlying cell proliferation and migration, J Neurophysiol, vol.101, pp.750-757, 2009. ,
Calcium channels and associated receptors in malignant brain tumor therapy, Mol Pharmacol, vol.90, pp.403-412, 2016. ,
Brain tumour cells interconnect to a functional and resistant network, Nature, vol.528, pp.93-101, 2015. ,
MicroRNA biogenesis pathways in cancer, Nat Rev Cancer, vol.15, pp.321-354, 2015. ,
NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by F. Lefranc et al, Cancer Treatment Reviews, vol.68, pp.145-154, 2018. ,
, regulating miR-21, miR-128, and miR-200, Neuro Oncol, vol.15, pp.691-706, 2013.
Extensive modulation of a set of microRNAs in primary glioblastoma, Biochem Biophys Res Commun, vol.334, pp.1351-1359, 2005. ,
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, Cancer Res, vol.65, pp.6029-6062, 2005. ,
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications, J Cell Mol Med, vol.15, pp.1636-1680, 2011. ,
Current progress on understanding MicroRNAs in glioblastoma multiforme, Genes Cancer, vol.3, pp.3-15, 2012. ,
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion, Mol Neurobiol, vol.47, pp.131-175, 2013. ,
MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies, CNS Neurol Disord: Drug Targets, vol.14, pp.222-260, 2015. ,
Regulation of cell proliferation and migration by miR-203 via GAS41/miR-10b axis in human glioblastoma cells, PLoS One, vol.11, p.159092, 2016. ,
Belonging to a network-microRNAs, extracellular vesicles, and the glioblastoma microenvironment, Neuro Oncol, vol.17, pp.652-62, 2015. ,
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM, Oncotarget, vol.7, pp.12937-50, 2016. ,
Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: state of the art, Semin Cell Dev Biol, vol.67, pp.23-31, 2017. ,
How cancer cells dictate their microenvironment: present roles of extracellular vesicles, Cell Mol Life Sci, vol.74, pp.697-713, 2017. ,
MicroRNA and extracellular vesicles in glioblastoma -Small but powerful, Brain Tumor Pathol, vol.33, pp.77-88, 2016. ,
Extracellular vesicles and MicroRNAs: their role in tumorigenicity and therapy for brain tumors, Cell Mol Neurobiol, vol.36, pp.361-76, 2016. ,
Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells, RNA Biol, vol.10, pp.1333-1377, 2013. ,
Tumour exosome integrins determine organotropic metastasis, Nature, vol.527, pp.329-364, 2015. ,
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma, Oncotarget, vol.8, pp.68769-79, 2017. ,
Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration, Transl Oncol, vol.6, pp.638-686, 2013. ,
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma, Oncotarget, vol.7, pp.33440-50, 2016. ,
Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development, Mol Cancer, vol.16, p.100, 2017. ,
Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death, Am J Physiol Cell Physiol, vol.303, pp.1070-1078, 2012. ,
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells, EMBO Mol Med, vol.4, pp.577-93, 2012. ,
Mitochondrial potassium channels in cell death, Biochem Biophys Res Commun, issue.17, pp.31226-31229, 2017. ,
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell, vol.11, pp.37-51, 2007. ,
K+ channels in apoptosis, J Membr Biol, vol.209, pp.3-20, 2006. ,
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas, Neuro Oncol, vol.19, pp.1316-1342, 2017. ,
Glutamate and the biology of gliomas, Glia, vol.59, pp.1181-1190, 2011. ,
Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications, Bull Cancer, vol.100, pp.829-864, 2013. ,
NF-kB-independent actions of sulfasalazine dissociate the CD95L-and Apo2L/TRAIL-dependent death signalling pathways in human malignant glioma cells, Cell Death Differ, vol.10, pp.1078-89, 2003. ,
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults, BMC Cancer, vol.9, p.372, 2009. ,
Seizures and gliomas-towards a single therapeutic approach, Nat Rev Neurol, vol.12, pp.204-220, 2016. ,
Does valproic acid improve survival in glioblastoma? A meta-analysis of randomized trials in newly diagnosed glioblastoma, J Clin Oncol, vol.34, pp.731-740, 2016. ,
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas, Cancer, vol.116, pp.1776-82, 2010. ,
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial, J Clin Oncol, vol.27, pp.4155-61, 2009. ,
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States, Clin Cancer Res, vol.16, pp.2443-2452, 2010. ,
ACT IV trial investigators: Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial, Lancet Oncol, vol.18, pp.1373-85, 2017. ,
Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models, J Neurosurg, vol.120, pp.854-63, 2014. ,
The chemical biology of clinically tolerated NMDA receptor antagonists, J Neurochem, vol.97, pp.1611-1637, 2006. ,
Competitive AMPA receptor antagonists, Med Res Rev, vol.27, pp.239-78, 2007. ,
Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion, Am J Physiol, vol.264, pp.361-370, 1993. ,
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma, J Clin Oncol, vol.24, pp.3644-50, 2006. ,
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601), Expert Opin Drug Deliv, vol.4, pp.175-86, 2007. ,
Imaging glioma extent with 131I-TM-601, J Nucl Med, vol.46, pp.580-586, 2005. ,
Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery, Biomaterials, vol.31, pp.8032-8074, 2010. ,
Targeted delivery of chlorotoxin-modified DNAloaded nanoparticles to glioma via intravenous administration, Biomaterials, vol.32, pp.2399-406, 2011. ,
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2, J Biol Chem, vol.278, pp.4135-4179, 2003. ,
Voltage-gated potassium channels as therapeutic targets, Nat Rev Drug Discov, vol.8, pp.982-1001, 2009. ,
Astemizole: an old anti-histamine as a new promising anti-cancer drug, Anticancer Agents Med Chem, vol.11, pp.307-321, 2011. ,
Approaches targeting K(V)10.1 open a novel window for cancer diagnosis and therapy, Curr Med Chem, vol.19, pp.675-82, 2012. ,
Antidepressant desipramine leads to C6 glioma cell autophagy: implication for the adjuvant therapy of cancer, Anticancer Agents Med Chem, vol.13, pp.254-60, 2013. ,
The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells, Biochem Biophys Res Commun, vol.413, pp.311-318, 2011. ,
Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide, Oncol Lett, vol.12, pp.2581-2590, 2016. ,
Development of Safe Drugs: The hERG Challenge, Med Res Rev, 2017. ,
Antihistamine drug withdrawn by manufacturer, BMJ, vol.319, p.7, 1999. ,
In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kv10.1, Eur Biophys J, vol.45, pp.721-754, 2016. ,
State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy, Am J Physiol Cell Physiol, vol.296, pp.701-711, 2009. ,
1 channel inhibition sensitizes malignant gliomas to temozolomide treatment, Oncotarget, vol.7, pp.30781-96, 2016. ,
BK K+ channel blockade inhibits radiationinduced migration/brain infiltration of glioblastoma cells, Oncotarget, vol.7, pp.14259-78, 2016. ,
Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity, Cell Death Dis, vol.4, p.561, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00848910